A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)
NCT 03970447 Brief Summary Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM…
Read more arrow_forwardNCT 03970447 Brief Summary Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardACTRN 12625000191493 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardACTRN 12622001514796 Brief Summary The aim of this study is to assess…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12621000418875 Brief Summary The MRI Linac is one of the newest…
Read more arrow_forward